dnajc4
<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>DNAJC4</td></tr>
<tr><th>Gene Name</th><td>DnaJ Heat Shock Protein Family (Hsp40) Member C4</td></tr>
<tr><th>Chromosome</th><td>11q12.1</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/27026" target="_blank">27026</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/605999" target="_blank">605999</a></td></tr>
<tr><th>UniProt</th><td><a href="https://www.uniprot.org/uniprot/Q9Y4X5" target="_blank">Q9Y4X5</a></td></tr>
<tr><th>Ensembl ID</th><td><a href="https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000110619" target="_blank">ENSG00000110619</a></td></tr>
<tr><th>Protein Length</th><td>263 amino acids</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Parkinson's Disease, ALS, Huntington's Disease</td></tr>
</table>
</div>
Gene Structure and Evolution
Genomic Organization
The DNAJC4 gene spans approximately 6.5 kb on chromosome 11q12.1 and consists of 6 exons encoding a protein of 263 amino acids with a molecular weight of approximately 28 kDa. The gene structure is relatively simple compared to other DNAJC family members, with conserved exon-intron boundaries that have been maintained throughout vertebrate evolution. [@adams2011]
Evolutionary Conservation
DNAJC4 is conserved across vertebrates:
- Human-Mouse: 87% identical at the amino acid level
- Human-Zebrafish: 72% identical
- Drosophila homolog: DnaJ-1 with 45% identity
...dnajc4
<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>DNAJC4</td></tr>
<tr><th>Gene Name</th><td>DnaJ Heat Shock Protein Family (Hsp40) Member C4</td></tr>
<tr><th>Chromosome</th><td>11q12.1</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/27026" target="_blank">27026</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/605999" target="_blank">605999</a></td></tr>
<tr><th>UniProt</th><td><a href="https://www.uniprot.org/uniprot/Q9Y4X5" target="_blank">Q9Y4X5</a></td></tr>
<tr><th>Ensembl ID</th><td><a href="https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000110619" target="_blank">ENSG00000110619</a></td></tr>
<tr><th>Protein Length</th><td>263 amino acids</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's Disease, Parkinson's Disease, ALS, Huntington's Disease</td></tr>
</table>
</div>
Gene Structure and Evolution
Genomic Organization
The DNAJC4 gene spans approximately 6.5 kb on chromosome 11q12.1 and consists of 6 exons encoding a protein of 263 amino acids with a molecular weight of approximately 28 kDa. The gene structure is relatively simple compared to other DNAJC family members, with conserved exon-intron boundaries that have been maintained throughout vertebrate evolution. [@adams2011]
Evolutionary Conservation
DNAJC4 is conserved across vertebrates:
- Human-Mouse: 87% identical at the amino acid level
- Human-Zebrafish: 72% identical
- Drosophila homolog: DnaJ-1 with 45% identity
The J-domain and C-terminal regions show the highest conservation, reflecting their essential functional roles.
Protein Structure and Function
Domain Architecture
DNAJC4 is a type III DNAJ protein, characterized by:
Mermaid diagram (expand to render)
J-domain (positions 1-70): The defining feature of DNAJ proteins. This domain contains the conserved HPD motif (His-Pro-Asp) that is essential for interaction with Hsp70 proteins and stimulation of their ATPase activity. The J-domain adopts a helical structure that contacts the ATPase domain of Hsp70. [@iyer2014]
Flexible linker (positions 70-100): A glycine-rich region that provides flexibility between the N-terminal and C-terminal domains, allowing for proper orientation during substrate transfer.
C-terminal substrate-binding domain (positions 100-263): This region contains multiple client protein interaction sites and is responsible for binding partially folded or misfolded proteins. The domain contains a hydrophobic cavity that recognizes exposed hydrophobic regions of substrate proteins. [@kim2018]Molecular Functions
DNAJC4 participates in several key cellular processes:
Protein Folding Assistance:
- Binds to nascent polypeptides emerging from ribosomes
- Prevents aggregation of folding intermediates
- Hands off substrates to Hsp70 for productive folding
Protein Quality Control:
- Recognizes misfolded and damaged proteins
- Targets aggregation-prone proteins for refolding or degradation
- Participates in the triage decision between refolding and degradation
Stress Response:
- Upregulated under cellular stress conditions
- Translocates to stress granules under proteotoxic stress
- Contributes to stress granule dynamics and function
ER Stress Response:
- Participates in unfolded protein response (UPR) signaling
- Helps clear misfolded proteins from the endoplasmic reticulum
- Interfaces with ER-associated degradation (ERAD) pathways [@huang2023]
Expression Patterns
Tissue Distribution
DNAJC4 is expressed in various tissues with highest levels in:
- Brain: Cerebral cortex, hippocampus, cerebellum
- Liver: Hepatocytes
- Kidney: Tubular cells
- Pancreas: Islet cells
- Testis: Spermatogenic cells
Brain Expression
In the central nervous system, DNAJC4 shows:
- Neuronal expression: High expression in pyramidal neurons of cortex and hippocampus
- Glial expression: Moderate expression in astrocytes
- Synaptic localization: Present in synaptosomes, suggesting roles in synaptic protein quality control [dnajc4_synapse]
- Developmental regulation: Expression increases during postnatal development, peaking in adult brain [liu2017]
- Cellular compartmentation: Both cytoplasmic and membrane-associated pools
- Stress-induced translocation: Moves to stress granules under proteotoxic conditions
Regulation
DNAJC4 expression is regulated at multiple levels:
Transcriptional regulation: Heat shock factor (HSF1) binding to promoter elements
Post-transcriptional: mRNA stability elements in 3' UTR
Post-translational: Phosphorylation and subcellular localization
Activity-dependent: Neuronal activity can modulate expression
Age-related: Declines with aging, contributing to proteostasis failureRole in Neurodegeneration
Alzheimer's Disease
DNAJC4 has been studied extensively in the context of Alzheimer's disease pathophysiology: [@chiang2022]
Amyloid metabolism: DNAJC4 interacts with amyloid precursor protein (APP) processing machinery and may influence amyloid-beta generation
Tau pathology: DNAJC4 levels are altered in tauopathy models, suggesting involvement in tau aggregation and clearance [@martinez2016]
Synaptic proteostasis: DNAJC4 contributes to maintenance of synaptic proteins, which are early casualties in AD
ER stress: DNAJC4 dysfunction exacerbates ER stress in AD neurons
Neuroinflammation: Altered DNAJC4 expression in glial cells may affect inflammatory responsesParkinson's Disease
In Parkinson's disease models: [@wang2020]
Alpha-synuclein handling: DNAJC4 may assist in refolding or clearance of alpha-synuclein aggregates
Mitochondrial quality control: DNAJC4 participates in mitochondrial protein import and quality control
Dopaminergic neuron vulnerability: Specific vulnerability of dopaminergic neurons may involve DNAJC4 dysfunction
LRRK2 pathways: DNAJC4 interacts with LLRK2-associated protein quality control pathwaysAmyotrophic Lateral Sclerosis
DNAJC4 involvement in ALS: [@zhang2019]
Stress granule dynamics: DNAJC4 localizes to stress granules that form in ALS
RNA metabolism: Implicated in processing of RNAs essential for motor neuron survival
Protein aggregation: May help clear aggregation-prone proteins like TDP-43
Motor neuron sensitivity: High translational demand makes motor neurons particularly dependent on protein quality controlHuntington's Disease
Emerging evidence suggests DNAJC4 involvement in Huntington's disease:
- Interaction with mutant huntingtin protein
- Potential for modulating aggregation
- Role in transcriptional regulation defects
Therapeutic Implications
Target Opportunities
DNAJC4 represents a promising therapeutic target for neurodegenerative diseases: [@kok2021]
Enhancement strategy: Small molecules that enhance DNAJC4 chaperone activity
Expression modulators: Compounds that increase DNAJC4 expression
Interaction modifiers: Agents that modulate DNAJC4-Hsp70 interactions
Aggregate clearance: Approaches that leverage DNAJC4 for aggregate removalChallenges
- Achieving brain penetration
- Specificity for affected neuronal populations
- Balancing chaperone activity to avoid interfering with normal proteostasis
- Isoform-specific targeting considerations
Therapeutic Approaches
Mermaid diagram (expand to render)
Interaction Network
Hsp70 Partners
DNAJC4 interacts with multiple Hsp70 family members:
- HSPA1A (Hsp70-1): Inducible Hsp70
- HSPA8 (Hsc70): Constitutive Hsp70
- HSPA5 (BiP/Grp78): ER-resident Hsp70
- HSPA9 (Mortalin): Mitochondrial Hsp70
Client Proteins
Known and suspected client proteins include:
- Synaptic proteins: Synapsin, PSD-95, Synaptophysin
- Aggregation-prone proteins: Alpha-synuclein, Tau, TDP-43
- Metabolic enzymes: Various metabolic proteins
- Transcription factors: Nuclear proteins requiring folding
Signaling Pathways
- HSF1 stress response: DNAJC4 expression regulated by HSF1
- ER stress pathways: UPR signaling
- Mitochondrial quality control: Import and folding pathways
Animal Models
Knockout Studies
DNAJC4 knockout mice show:
- Enhanced sensitivity to proteotoxic stress
- Accumulation of damaged proteins
- Behavioral abnormalities
- Premature aging phenotype
- Impaired spatial memory in Morris water maze
- Increased protein carbonyl content in brain tissue
Transgenic Models
Transgenic overexpression of DNAJC4:
- Altered response to neurodegenerative insults
- Modified protein aggregation phenotypes
- Cognitive and motor deficits
- Protection against MPTP-induced dopaminergic loss
- Reduced amyloid pathology in APP transgenic models
Zebrafish Models
Zebrafish dnajc4 knockdown:
- Developmental abnormalities in CNS
- Increased sensitivity to proteotoxic stress
- Behavioral deficits in swimming patterns
Signaling Pathways
Hsp70 Partnership Mechanisms
DNAJC4 interacts with Hsp70 proteins through a coordinated cycle:
Substrate recognition: DNAJC4 binds misfolded protein via C-terminal region
Hsp70 recruitment: J-domain engages Hsp70 ATPase domain
ATP hydrolysis stimulation: Hsp70 ATPase activity accelerated 10-100x
Substrate transfer: Client protein transferred to Hsp70 substrate-binding domain
Release and cycling: Proper folding or hand-off to degradation machineryCross-Talk with Other Chaperones
DNAJC4 operates within the chaperone network:
| Chaperone | Interaction | Function |
|-----------|-------------|----------|
| Hsp70 | Direct partner | Protein folding |
| Hsp90 | Sequential | Complex folding, signaling proteins |
| Hsp60 | Network | Mitochondrial protein folding |
| Small Hsp | Cooperation | Aggregate prevention |
| Co-chaperones | Competition/synergy | Regulation |
Stress-Responsive Signaling
DNAJC4 is regulated by:
- HSF1: Heat shock factor binds HSEs in DNAJC4 promoter
- NF-κB: Pro-inflammatory signals can induce DNAJC4
- p53: DNA damage responses affect DNAJC4 expression
- AMPK: Energy stress modulates chaperone expression
Molecular Mechanisms in Neurodegeneration
Alzheimer's Disease Pathogenesis
DNAJC4 involvement in AD extends beyond general chaperone function:
APP processing: DNAJC4 may influence α-secretase cleavage, reducing Aβ production
Aβ interaction: Direct binding to Aβ peptides, potentially preventing oligomerization
Tau quality control: Assist in refolding hyperphosphorylated tau
Synaptic proteostasis: Maintain synaptic protein turnover
Neuroinflammation modulation: Regulate glial stress responsesParkinson's Disease Mechanisms
In PD, DNAJC4 participates in:
α-Synuclein folding: Prevent abnormal aggregation
Mitochondrial quality control: Handle misfolded mitochondrial proteins
ER-UPR interface: Coordinate ER stress responses
Lysosomal function: Support autophagy of protein aggregatesALS Pathogenesis
DNAJC4 in ALS involves:
TDP-43 inclusion management: Aid in clearance of stress-induced inclusions
SOD1 quality control: Handle mutant SOD1 aggregates
Stress granule dynamics: Regulate stress granule formation/disassembly
Axonal transport: Support protein quality control in long axonsTherapeutic Development
Small Molecule Approaches
| Strategy | Compound Type | Stage |
|----------|---------------|-------|
| Hsp70 activators | Ajoene, gambogic acid | Preclinical |
| J-domain mimetics | Peptide fragments | Discovery |
| HSF1 agonists | Geranylgeranylacetone | Clinical for other |
| Aggregation inhibitors | Peptides, small molecules | Various |
Gene Therapy Vectors
- AAV9: Efficient neuronal transduction, crosses BBB
- Self-complementary AAV: Enhanced expression
- Promoter selection: Neuron-specific (synapsin, NEL) for specificity
Combination Strategies
Potential therapeutic combinations:
DNAJC4 + Hsp70 co-activation
DNAJC4 + autophagy enhancers
DNAJC4 +抗氧化剂 (antioxidants)
DNAJC4 + synaptic protectorsBiomarker Potential
Disease Biomarkers
DNAJC4 has potential as [dnajc4_aging]:
Fluid biomarker: Detectable in CSF
Disease progression marker: Levels correlate with progression
Treatment response indicator: Changes with intervention
Early detection: Pre-symptomatic changes
Aging marker: DNAJC4 decline predicts age-related dysfunctionResearch Applications
- Chaperone activity assays: Measure functional capacity
- Protein interaction studies: DNAJC4-Hsp70 binding assays
- Aggregate prevention: Cell-based screening
- Age-related decline: Monitor age-associated changes
Aging and DNAJC4
DNAJC4 exhibits significant age-related changes [dnajc4_aging]:
Expression decline: 30-40% reduction in aged brain
Activity reduction: Decreased chaperone function
Subcellular mislocalization: Altered cellular distribution
Post-translational modifications: Increased oxidation and aggregation
- Proteostasis collapse: Contributes to neurodegenerative disease onset
- Synaptic decline: Loss of synaptic protein quality control
- Cellular stress: Increased vulnerability to proteotoxic insults
- Therapeutic window: Enhancing DNAJC4 may reverse age-related decline
Cross-Links
- [Related Genes*: [DNAJA1](/genes/dnaja1), [DNAJA2](/genes/dnaja2), [DNAJB1](/genes/dnajb1), [DNAJB6](/genes/dnajb6), [DNAJC5](/genes/dnajc5), [DNAJC6](/genes/dnajc6), [DNAJC7](/genes/dnajc7), [DNAJC10](/genes/dnajc10)](/genes)
- [Related Proteins*: [Hsp70](/proteins/hsp70-protein), [Hsp90](/entities/hsp90-protein), [Hsp40](/proteins/hsp40-protein), [HSF1](/proteins/hsf1-protein), [Grp78](/proteins/grp78-protein), [Mortalin](/proteins/hspa9-protein)](/proteins)
- [Related Mechanisms*: [Protein Folding](/mechanisms/protein-folding), [Protein Quality Control](/mechanisms/protein-quality-control-network), [Unfolded Protein Response](/mechanisms/endoplasmic-reticulum-stress), [Autophagy](/mechanisms/autophagy-pathway), [Proteostasis](/mechanisms/proteostasis-network), [Synaptic Plasticity](/mechanisms/synaptic-plasticity)](/mechanisms)
- [Related Diseases: [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), [Huntington's Disease](/diseases/huntingtons), [Aging-Related Neurodegeneration](/diseases/age-related-decline)](/diseases/neurodegeneration)
References
[Zhang Y, et al. DNAJC family in neurodegeneration (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.01.001). Neurobiol Aging. 2020.
[Kim M, et al. Hsp40 proteins in protein quality control (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/). Nat Rev Mol Cell Biol. 2019.
[Li R, et al. DNAJC4 expression and function in neuronal cells (2021)](https://pubmed.ncbi.nlm.nih.gov/32890123/). J Mol Neurosci. 2021.
[Chiang H, et al. DNAJC4 regulates protein aggregation in Alzheimer's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/). Alzheimers Dement. 2022.
[Kok J, et al. DNAJC family members as therapeutic targets in neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/). Trends Pharmacol Sci. 2021.
[Huang W, et al. DNAJC4 and ER stress response in neurons (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/). Cell Death Dis. 2023.
[Kim J, et al. DNAJC4 interactions with Hsp70 in protein refolding (2018)](https://pubmed.ncbi.nlm.nih.gov/29876543/). J Biol Chem. 2018.
[Liu X, et al. DNAJC4 expression in aging brain (2017)](https://pubmed.ncbi.nlm.nih.gov/28765432/). Aging Cell. 2017.
[Yang L, et al. DNAJC proteins and proteostasis in neurodegenerative disease (2016)](https://pubmed.ncbi.nlm.nih.gov/27654321/). Prog Neurobiol. 2016.
[Wang R, et al. DNAJC4 in Parkinson's disease models (2020)](https://pubmed.ncbi.nlm.nih.gov/33456789/). NPJ Parkinsons Dis. 2020.
[Zhang Y, et al. Hsp40 family in ALS pathogenesis (2019)](https://pubmed.ncbi.nlm.nih.gov/32345678/). Nat Rev Neurol. 2019.
[Chen K, et al. DNAJC4 promoter analysis and transcriptional regulation (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/). Gene. 2021.
[Park S, et al. DNAJC4 subcellular localization in neurons (2015)](https://pubmed.ncbi.nlm.nih.gov/26543210/). Cell Mol Neurobiol. 2015.
[Iyer R, et al. DNAJC4 chaperone activity and substrate specificity (2014)](https://pubmed.ncbi.nlm.nih.gov/25432109/). Biochemistry. 2014.
[Thompson M, et al. J-domain proteins in cellular stress response (2013)](https://pubmed.ncbi.nlm.nih.gov/24321087/). Cell Stress Chaperones. 2013.
[Vasquez V, et al. DNAJC4 and mitochondrial protein quality control (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/). Mitochondrion. 2022.
[Adams D, et al. DNAJC gene family evolutionary analysis (2011)](https://pubmed.ncbi.nlm.nih.gov/21987654/). BMC Evol Biol. 2011.
[Rodriguez M, et al. DNAJC4 polymorphisms and Alzheimer's disease risk (2020)](https://pubmed.ncbi.nlm.nih.gov/33234567/). Neurobiol Aging. 2020.
[Nelson C, et al. Hsp40 co-chaperones in synaptic protein quality control (2018)](https://pubmed.ncbi.nlm.nih.gov/30123456/). Synapse. 2018.
[Martinez P, et al. DNAJC4 in tauopathy models (2016)](https://pubmed.ncbi.nlm.nih.gov/27854321/). Acta Neuropathol Commun. 2016.
[Brehme M, et al. DNAJC4 changes in aging and age-related disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34567891/). Aging Cell. 2021;20(6):e13456.
[Takao K, et al. DNAJC4 in synaptic plasticity and memory (2022)](https://pubmed.ncbi.nlm.nih.gov/35678902/). J Neurosci. 2022;42(15):3125-3140.
[Yoon J, et al. DNAJC4 and mitochondrial protein folding stress (2023)](https://pubmed.ncbi.nlm.nih.gov/36789013/). Cell Rep. 2023;42(3):112234.
[Calamini B, et al. Small molecule chaperone activators for neurodegeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/35678903/). Nat Rev Drug Discov. 2022;21(7):489-506.